{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:48:26Z","timestamp":1760150906344,"version":"build-2065373602"},"reference-count":34,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Although the routine use of immunohistochemistry has improved the accuracy of histopathologic diagnosis in clinical practice, new methods for discovering novel diagnostic markers are still needed. We sought new diagnostic markers for malignant pleural mesothelioma (MPM) using a reverse translational approach with limited archival tissues from a very rare case. Total RNA extracted from formalin-fixed paraffin-embedded (FFPE) tissues of a synchronous collision tumor consisting of MPM and pulmonary adenocarcinoma (PAC) was employed for gene expression profiling (GEP) analysis. Among the 54 genes selected by GEP analysis, we finally identified the following two candidate MPM marker genes: PHGDH and TRIM29. Immunohistochemical analysis of 48 MM and 20 PAC cases showed that both PHGDH and TRIM29 had sensitivity and specificity almost equivalent to those of calretinin (sensitivity 50% and 46% vs. 63%, and specificity 95% and 100% vs. 100%, respectively). Importantly, of the 23 epithelioid MMs, all 3 calretinin-negative cases were positive for TRIM29. These two markers may be diagnostically useful for immunohistochemical distinction between MPMs and PACs. This successful reverse translational approach based on FFPE samples from one very rare case encourages the further use of such samples for the development of novel diagnostic markers.<\/jats:p>","DOI":"10.3390\/diagnostics12020316","type":"journal-article","created":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T21:59:55Z","timestamp":1643320795000},"page":"316","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of Novel Diagnostic Markers for Malignant Pleural Mesothelioma Using a Reverse Translational Approach Based on a Rare Synchronous Tumor"],"prefix":"10.3390","volume":"12","author":[{"given":"Tomoaki","family":"Naka","sequence":"first","affiliation":[{"name":"Department of Surgical Pathology, Hokkaido University Hospital, Sapporo 060-8648, Japan"},{"name":"Department of Diagnostic Pathology, Faculty of Medicine, Hokkaido University, Sapporo 060-8638, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3128-1477","authenticated-orcid":false,"given":"Yutaka","family":"Hatanaka","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, Hokkaido University Hospital, Sapporo 060-8648, Japan"},{"name":"Research Division of Genome Companion Diagnostics, Hokkaido University Hospital, Sapporo 060-8648, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Tabata","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, Hokkaido University Hospital, Sapporo 060-8648, Japan"},{"name":"Department of Cardiovascular and Thoracic Surgery, Graduate School of Medicine, Hokkaido University, Sapporo 060-8638, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Takasawa","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, Hokkaido University Hospital, Sapporo 060-8648, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Akiyama","sequence":"additional","affiliation":[{"name":"Research Division of Genome Companion Diagnostics, Hokkaido University Hospital, Sapporo 060-8648, Japan"},{"name":"New Projects Development Division, Toray Industries, Inc., Kamakura 248-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1759-4215","authenticated-orcid":false,"given":"Yasuhiro","family":"Hida","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Thoracic Surgery, Graduate School of Medicine, Hokkaido University, Sapporo 060-8638, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, Hokkaido University Hospital, Sapporo 060-8648, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanako C.","family":"Hatanaka","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, Hokkaido University Hospital, Sapporo 060-8648, Japan"},{"name":"Research Division of Genome Companion Diagnostics, Hokkaido University Hospital, Sapporo 060-8648, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Mitsuhashi","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, Hokkaido University Hospital, Sapporo 060-8648, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Kushitani","sequence":"additional","affiliation":[{"name":"Department of Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8551, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4986-2109","authenticated-orcid":false,"given":"Vishwa Jeet","family":"Amatya","sequence":"additional","affiliation":[{"name":"Department of Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8551, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Takeshima","sequence":"additional","affiliation":[{"name":"Department of Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8551, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouki","family":"Inai","sequence":"additional","affiliation":[{"name":"Department of Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8551, Japan"},{"name":"Pathological Diagnostic Center, Inc., Hiroshima 730-0029, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kichizo","family":"Kaga","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Thoracic Surgery, Graduate School of Medicine, Hokkaido University, Sapporo 060-8638, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Matsuno","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, Hokkaido University Hospital, Sapporo 060-8648, Japan"},{"name":"Department of Diagnostic Pathology, Faculty of Medicine, Hokkaido University, Sapporo 060-8638, Japan"},{"name":"Research Division of Genome Companion Diagnostics, Hokkaido University Hospital, Sapporo 060-8648, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajim.20246","article-title":"Estimation of future mortality from pleural malignant mesothelioma in Japan based on an age-cohort model","volume":"49","author":"Murayama","year":"2005","journal-title":"Am. J. Ind. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"112","DOI":"10.5271\/sjweh.520","article-title":"Incidence rates of malignant mesothelioma in Denmark and predicted future number of cases among men","volume":"26","author":"Andersson","year":"2000","journal-title":"Scand. J. Work. Environ. Health"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/ajim.20167","article-title":"Mesothelioma in household members of asbestos-exposed workers: 32 United States cases since 1990","volume":"47","author":"Miller","year":"2005","journal-title":"Am. J. Ind. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1080\/19338244.2020.1747380","article-title":"Potential years of life and productivity loss due to malignant mesothelioma in Turkey","volume":"75","author":"Metintas","year":"2020","journal-title":"Arch. Environ. Occup. Health"},{"key":"ref_5","first-page":"3080","article-title":"Gene expression profiling of malignant mesothelioma","volume":"9","author":"Singhal","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/S0002-9440(10)62492-3","article-title":"Identification of Novel Candidate Oncogenes and Tumor Suppressors in Malignant Pleural Mesothelioma Using Large-Scale Transcriptional Profiling","volume":"166","author":"Gordon","year":"2005","journal-title":"Am. J. Pathol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1158\/0008-5472.CAN-05-3907","article-title":"Global Gene Expression Profiling of Pleural Mesotheliomas: Overexpression of Aurora Kinases and P16\/CDKN2A Deletion as Prognostic Factors and Critical Evaluation of Microarray-Based Prognostic Prediction","volume":"66","author":"Chuai","year":"2006","journal-title":"Cancer Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"5944","DOI":"10.1158\/1078-0432.CCR-06-1059","article-title":"Gene Expression Signatures Differentiate Ovarian\/Peritoneal Serous Carcinoma from Diffuse Malignant Peritoneal Mesothelioma","volume":"12","author":"Davidson","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Crispi, S., Calogero, R.A., Santini, M., Mellone, P., Vincenzi, B., Citro, G., Vicidomini, G., Fasano, S., Meccariello, R., and Cobellis, G. (2009). Global Gene Expression Profiling of Human Pleural Mesotheliomas: Identification of Matrix Metalloproteinase 14 (MMP-14) as Potential Tumour Target. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0007016"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/annonc\/mdu127","article-title":"Expression profiling stratifies mesothelioma tumors and signifies deregulation of spindle checkpoint pathway and microtubule network with therapeutic implications","volume":"25","author":"Suraokar","year":"2014","journal-title":"Ann. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/modpathol.2016.181","article-title":"MUC4, a novel immunohistochemical marker identified by gene expression profiling, differentiates pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma","volume":"30","author":"Amatya","year":"2017","journal-title":"Mod. Pathol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jmoldx.2019.12.009","article-title":"Differential Diagnosis of Malignant Pleural Mesothelioma on Cytology","volume":"22","author":"Bruno","year":"2020","journal-title":"J. Mol. Diagn."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Morani, F., Bisceglia, L., Rosini, G., Mutti, L., Melaiu, O., Landi, S., and Gemignani, F. (2021). Identification of Overexpressed Genes in Malignant Pleural Mesothelioma. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22052738"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cancergen.2014.08.005","article-title":"Genomic microarray analysis on formalin-fixed paraffin-embedded material for uveal melanoma prognostication","volume":"207","author":"Minca","year":"2014","journal-title":"Cancer Genet."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jmoldx.2015.02.002","article-title":"Comparing Platforms for Messenger RNA Expression Profiling of Archival Formalin-Fixed, Paraffin-Embedded Tissues","volume":"17","author":"Tyekucheva","year":"2015","journal-title":"J. Mol. Diagn."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13000-016-0488-0","article-title":"Comparative genetic analysis of a rare synchronous collision tumor composed of malignant pleural mesothelioma and primary pulmonary adenocarcinoma","volume":"11","author":"Naka","year":"2016","journal-title":"Diagn. Pathol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1115050","article-title":"Fibulin-3 as a Blood and Effusion Biomarker for Pleural Mesothelioma","volume":"367","author":"Pass","year":"2012","journal-title":"New Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"S369","DOI":"10.21037\/jtd.2017.10.158","article-title":"Overexpressed genes in malignant pleural mesothelioma: Implications in clinical management","volume":"10","author":"Barone","year":"2018","journal-title":"J. Thorac. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/PAI.0000000000000099","article-title":"Different Cutoff Values for Thyroid Transcription Factor-1 Antibodies in the Diagnosis of Lung Adenocarcinoma","volume":"23","author":"Smits","year":"2015","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.molonc.2015.05.003","article-title":"High level PHGDH expression in breast is predominantly associated with keratin 5-positive cell lineage independently of malignancy","volume":"9","author":"Gromova","year":"2015","journal-title":"Mol. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/j.1755-148X.2011.00919.x","article-title":"PHGDH amplification and altered glucose metabolism in human melanoma","volume":"24","author":"Mullarky","year":"2011","journal-title":"Pigment. Cell Melanoma Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0378-1119(00)00009-3","article-title":"Nucleotide sequence and differential expression of the human 3-phosphoglycerate dehydrogenase gene","volume":"245","author":"Cho","year":"2000","journal-title":"Gene"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/IGC.0b013e3182a0c068","article-title":"Expression and Clinical Significance of Phosphoglycerate Dehydrogenase and Squamous Cell Carcinoma Antigen in Cervical Cancer","volume":"23","author":"Jing","year":"2013","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.humpath.2013.04.005","article-title":"Novel markers of squamous differentiation in the urinary bladder","volume":"44","author":"Huang","year":"2013","journal-title":"Hum. Pathol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/nrc3139","article-title":"TRIM proteins and cancer","volume":"11","author":"Hatakeyama","year":"2011","journal-title":"Nat. Cancer"},{"key":"ref_26","first-page":"S71","article-title":"Expression of a Candidate Ataxia-Telangiectasia Group D Gene in Cultured Fibroblast Cell Lines and Human Tissues","volume":"66","author":"Hosoi","year":"1994","journal-title":"Int. J. Radiat. Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1007\/s13277-013-1588-z","article-title":"Expression levels of serine\/glycine metabolism-related proteins in triple negative breast cancer tissues","volume":"35","author":"Noh","year":"2014","journal-title":"Tumor Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.acthis.2013.12.009","article-title":"TRIM29 as a novel prostate basal cell marker for diagnosis of prostate cancer","volume":"116","author":"Kanno","year":"2014","journal-title":"Acta Histochem."},{"key":"ref_29","first-page":"2296","article-title":"TRIM29 regulates the p63-mediated pathway in cervical cancer cells","volume":"1853","author":"Masuda","year":"2015","journal-title":"Biochim. et Biophys. Acta (BBA)\u2014Bioenerg."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1038\/s41388-018-0646-9","article-title":"ATDC mediates a TP63-regulated basal cancer invasive program","volume":"38","author":"Palmbos","year":"2019","journal-title":"Oncogene"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.3892\/ol.2015.3623","article-title":"Tripartite motif-containing 29 as a novel biomarker in non-small cell lung cancer","volume":"10","author":"Song","year":"2015","journal-title":"Oncol. Lett."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.celrep.2017.05.067","article-title":"PHGDH Defines a Metabolic Subtype in Lung Adenocarcinomas with Poor Prognosis","volume":"19","author":"Zhang","year":"2017","journal-title":"Cell Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.tranon.2016.08.003","article-title":"High Expression of PHGDH Predicts Poor Prognosis in Non\u2013Small Cell Lung Cancer","volume":"9","author":"Zhu","year":"2016","journal-title":"Transl. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.7150\/thno.23177","article-title":"Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase","volume":"8","author":"Dong","year":"2018","journal-title":"Theranostics"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/12\/2\/316\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:08:37Z","timestamp":1760134117000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/12\/2\/316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,27]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["diagnostics12020316"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics12020316","relation":{},"ISSN":["2075-4418"],"issn-type":[{"type":"electronic","value":"2075-4418"}],"subject":[],"published":{"date-parts":[[2022,1,27]]}}}